XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Oct. 31, 2023
Oct. 31, 2022
EXPENSES    
Accretion expense $ 30,113 $ 28,963
Consulting 52,583 105,570
Directors' fees 28,022 20,000
Filing and regulatory 12,907 8,550
Foreign exchange loss 12,987 40,958
General and administrative 145,159 80,883
Geological, mineral, and prospect costs 361,525 123,989
Interest expense 63,543 97,815
Professional fees 337,541 154,096
Promotion and shareholder communication 20,011 7,948
Salaries 84,301 33,750
Share-based compensation 90,361 0
Loss (1,239,053) (702,522)
Gain (loss) on fair value adjustment on derivative liability (82,481) 17,984
Write-off on receivable (64,438) 0
Other income 7,547 0
Net loss and comprehensive loss for the period $ (1,378,425) $ (684,538)
Basic loss per common share (in dollars per share) $ (0.03) $ (0.02)
Diluted loss per common share (in dollars per share) $ (0.03) $ (0.02)
Weighted average number of common shares outstanding (basic) (in shares) 40,362,800 32,787,798
Weighted average number of common shares outstanding (diluted) (in shares) 40,362,800 32,787,798